Navigation Links
Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Date:8/19/2007

in India, Cotara is currently in a dosimetry and dose confirmation trial in glioblastoma patients at leading U.S. academic brain cancer centers. Cotara has been granted orphan drug status and fast track designation for the treatment of glioblastoma multiforme and anaplastic astrocytoma by the U.S. Food and Drug Administration.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing three separate clinical programs in cancer and HCV infection in the U.S. and India with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (http://www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at http://www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to, the risk that the Company will not be able to enroll a sufficient number of patients to complete the clinical study, the risk that enrollment will be slower than expected, the risk that the results from the clinical study will not be consistent with the results from the previous clinical studies supporting the potential efficacy of Cotara in brain cancer, and the un
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Reports Positive Top-Line Results in Bavituximab Combination Therapy Trial in Advanced Cancer Patients
2. Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine
3. Peregrine Pharmaceuticals Highlights Significant Advances in the Companys Clinical and Preclinical Cancer Programs Presented This Week at the AACR Annual Meeting
4. Data Presented at AACR Meeting Shows Peregrines Immunocytokine Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in Preclinical Studies
5. Data Presented at AACR Meeting Show Peregrines Bavituximab Equivalent Can Generate Curative Immune Responses as Part of a Vaccine-Like Regimen in Preclinical Models of Aggressive Brain Cancer
6. Data Presented at AACR Meeting Shows Peregrines Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models
7. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... The American Association for Homecare (AAHomecare), along with ... , announced today the filing of a lawsuit ... , asking that the scheduled July 1 expansion of the ... be stopped because of serious licensing irregularities. The ... (HHS) Secretary Kathleen Sebelius as the defendant. HHS ...
(Date:6/19/2013)... SUNNYVALE, Calif. , June 19, 2013 ... today announced that The New England Journal of ... a Phase 1b/2 study evaluating the investigational oral Bruton,s ... chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). ... patients with relapsed/refractory CLL or SLL, even in patients ...
(Date:6/19/2013)... CHICAGO , June 19, 2013 The Physician-Patient ... reduce alarm fatigue. The need to urgently address ... in its Sentinel Event Alert #50 , "Medical device alarm ... Alert database, between January 2008 and June 2012, there were ... 80 resulted in death (82%) , 13 resulted in ...
Breaking Medicine Technology:AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 2AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 3AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 4AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 5Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 2Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 4Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 5Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 6Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3
... , ATLANTA , March 16 ... developing and delivering unique extracellular matrix (ECM) biomaterial devices ... cardiovascular tissue, announced today that investigators from the ... and CorMatrix Cardiovascular, Inc. demonstrated that an injectable ...
... March 16 AstraZeneca (NYSE: AZN ) ... (A Study of PLAT elet Inhibition and Patient ... patients with acute coronary syndromes (ACS) who took the investigational ... heart bypass surgery (coronary artery bypass graft, CABG) compared to ...
Cached Medicine Technology:CorMatrix Announces Publication of Pre-Clinical Data in Journal of American College of Cardiology (JACC) Demonstrating the Role of CorMatrix ECM(TM) Technology in Remodeling Cardiac Tissue 2CorMatrix Announces Publication of Pre-Clinical Data in Journal of American College of Cardiology (JACC) Demonstrating the Role of CorMatrix ECM(TM) Technology in Remodeling Cardiac Tissue 3CorMatrix Announces Publication of Pre-Clinical Data in Journal of American College of Cardiology (JACC) Demonstrating the Role of CorMatrix ECM(TM) Technology in Remodeling Cardiac Tissue 4CorMatrix Announces Publication of Pre-Clinical Data in Journal of American College of Cardiology (JACC) Demonstrating the Role of CorMatrix ECM(TM) Technology in Remodeling Cardiac Tissue 5CorMatrix Announces Publication of Pre-Clinical Data in Journal of American College of Cardiology (JACC) Demonstrating the Role of CorMatrix ECM(TM) Technology in Remodeling Cardiac Tissue 6New PLATO Sub-Analysis of CABG Patients Presented at ACC 2New PLATO Sub-Analysis of CABG Patients Presented at ACC 3New PLATO Sub-Analysis of CABG Patients Presented at ACC 4New PLATO Sub-Analysis of CABG Patients Presented at ACC 5New PLATO Sub-Analysis of CABG Patients Presented at ACC 6New PLATO Sub-Analysis of CABG Patients Presented at ACC 7
(Date:6/20/2013)... (PRWEB) June 20, 2013 Pedata RV ... vehicle sales, warns campers that improperly handled food can cause ... Now that summertime has arrived, many RV campers are enjoying ... Whether they are eating outdoors at the campground or dining ... ever present and should be avoided at all costs. , ...
(Date:6/20/2013)... 2013 TASC, a national leader ... new service to deal with funding the Patient-Centered ... Protection & Affordable Care Act (PPACA), the PCORI ... clinical effectiveness, and appropriateness" of different medical treatments. ... its own, with funding in part by employer-paid ...
(Date:6/20/2013)... Startups who need to scale up quickly, mid-market ... markets, and international companies that want to do business ... outsourcing company to help them explore opportunities for ... Sales Partners is a collaboration of successful “boots-on-the-ground” business ... owners, Strategy Sales Partners increases sales through customized programs ...
(Date:6/19/2013)... Everyone is looking for ways to improve general health. ... so. It is called Skin Brushing . Skin Brushing can ... day - to improve health and skin quality. It is ... , Skin Brushing improves general health because:, , ... system to drain toxins , it clears skins of ...
(Date:6/19/2013)... Harbor, Florida (PRWEB) June 19, 2013 Go ... and Clothing Optional Resorts for over 25 Years. ... enjoy nude beaches, nude pools, nude bars and nude hot ... and lifestyle clients alike. When SuperClubs re-branded the resort ... occupancy of the nude side of the Resort fell off ...
Breaking Medicine News(10 mins):Health News:Pedata RV Center Warns Campers of the Dangers of Mishandled Food 2Health News:Pedata RV Center Warns Campers of the Dangers of Mishandled Food 3Health News:TASC Service Helps Employers Handle New Burdens for Health Reimbursement Arrangement Plans 2Health News:Strategy Sales Partners Launches to Provide Sales Outsourcing Assistance to Businesses 2Health News:Strategy Sales Partners Launches to Provide Sales Outsourcing Assistance to Businesses 3Health News:A Fast and Fun Way to Better Skin Quality and Overall Health, says Sublime Beauty® 2Health News:The Former Breezes Resort is Re-Opened by Blue Diamond Resorts as the Original Grand Lido Negril Announced Go Classy Tours 2
... 23 Family Research Council,(FRC) President Tony ... Waxman,s biased abstinence education hearing today before,the ... "Chairman Henry Waxman,s hostility to abstinence education, ... by this biased hearing.,Chairman Waxman invited seven ...
... funds and awareness, EAGAN, Minn., April 23 ... supply chain management, knows the significance of,teamwork. In ... its K2 Cares program has joined the Parkinson ... fight against this debilitating,disease is Strategic Warehousing, an ...
... of a myocardial infarction is not higher for women ... rzteblatt International (Dtsch Arztebl Int 2008; 105(15): 279-85), PD ... this widely held view. , ( http://www.aerzteblatt-international.de/v4/archiv/pdf.asp?id=59860 ) ... data from AOK (a large general statutory health insurance ...
... Mother,s Day is traditionally filled,with joy and honor for ... of Mother,s Day was nearly not a cause for,celebration., ... disease. After she and,her husband tried unsuccessfully for three years ... and underwent a barrage of tests, only to be,declined help ...
... Reform Proposals Have Little Impact on Employer Health Care Offerings Thus ... ... 23 Most U.S. companies do,not support a single-payer health care system ... research by Watson Wyatt Worldwide, a leading,global consulting firm, and the National ...
... April 23 Dr. Vinton G. Cerf, Vice ... Dr. Robert E. Kahn,Chairman, CEO & President, Corporation ... Prize for Creation of network,architecture and communication protocol ... of Medical Genetics, the McKusick-Nathans,Institute of Genetic Medicine ...
Cached Medicine News:Health News:Waxman Sham Hearing Distorts Abstinence Education Benefits 2Health News:K2 Logistics & Strategic Warehousing Join The Parkinson Association of Minnesota (PAM) Team! 2Health News:K2 Logistics & Strategic Warehousing Join The Parkinson Association of Minnesota (PAM) Team! 3Health News:Mother's Day Gives Woman Reason to Celebrate Life's Most Precious Gift 2Health News:Most Companies Oppose Single-Payer Health Care System, State Coverage Mandates 2
... protection Properly manufactured radiation protective eyewear ... Our high quality frames and materials offer ... weight. Our lenses are made of Schott ... industry standards. Most Pulse Glasses are offered ...
... Both lenses and frames are designed with ... mind. Our lenses are Schott RS-520 (also called ... shielding glass. These lenses meet standards, as set ... prism correction. ,While our eyewear is protecting ...
... designed with the safety and comfort of the ... (also called SF-6) leaded glass, the industry standard ... as set for optical clarity, visible light transmission, ... is protecting your eyes, it also helps you ...
... are designed with the safety and comfort of ... RS-520 (also called SF-6) leaded glass, the industry ... standards, as set for optical clarity, visible light ... eyewear is protecting your eyes, it also helps ...
Medicine Products: